Memantine
Memantine is a pharmaceutical drug with 155 clinical trials. Currently 12 active trials ongoing. Historical success rate of 88.1%.
Success Metrics
Based on 104 completed trials
Phase Distribution
Phase Distribution
20
Early Stage
48
Mid Stage
70
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
85.2%
104 of 122 finished
14.8%
18 ended early
12
trials recruiting
155
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Escalating Doses of Memantine in Down Syndrome (MEDS-123)
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
Clinical Trials (155)
Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Escalating Doses of Memantine in Down Syndrome (MEDS-123)
Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients
Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases
Behavioral Treatment and Memantine in Body Focused Repetitive Behaviors
Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease
Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NTS-WBRT in Brain Metastases
Neuroprotection of Memantine and Rosuvastatin
Satisfaction With Orodispersible vs Conventional Memantine in Moderate to Severe Alzheimer's Disease
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 155